Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives

References

• Judge A, Dodd MS. Metabolism. Essays Biochem. 2020;64(4):607–647. doi:10.1042/ebc2019004132830223
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Sun L, Suo C, Li ST, Zhang H, Gao P. Metabolic reprogramming for cancer cells and their microenvironment: beyond the Warburg effect. Biochim Biophys Acta. 2018;1870(1):51–66. doi:10.1016/j.bbcan.2018.06.005
   Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.30913298683
   PubMed Web of Science ®Google Scholar
• Icard P, Shulman S, Farhat D, Steyaert JM, Alifano M, Lincet H. How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist Updat. 2018;38:1–11. doi:10.1016/j.drup.2018.03.00129857814
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.116080919460998
   PubMed Web of Science ®Google Scholar
• Yang J, Ren B, Yang G, et al. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci. 2020;77(2):305–321. doi:10.1007/s00018-019-03278-z31432232
   PubMed Web of Science ®Google Scholar
• Lin J, Xia L, Liang J, et al. The roles of glucose metabolic reprogramming in chemo- and radio-resistance. J Exp Clin Cancer Res. 2019;38(1):218. doi:10.1186/s13046-019-1214-z31122265
   PubMed Web of Science ®Google Scholar
• Hombach S, Non-coding KM. RNAs: classification, biology and functioning. Adv Exp Med Biol. 2016;937:3–17. doi:10.1007/978-3-319-42059-2_127573892
   PubMed Web of Science ®Google Scholar
• Lin S, Zhen Y, Guan Y, Yi H. Roles of wnt/β-catenin signaling pathway regulatory long non-coding RNAs in the pathogenesis of non-small cell lung cancer. Cancer Manag Res. 2020;12:4181–4191. doi:10.2147/cmar.S24151932581590
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388. doi:10.1080/15476286.2015.102027125746834
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang W, Zhu W, et al. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019;20(22). doi:10.3390/ijms20225573
   Web of Science ®Google Scholar
• Zhang Z, Fang E, Rong Y, et al. Hypoxia-induced lncRNA CASC9 enhances glycolysis and the epithelial-mesenchymal transition of pancreatic cancer by a positive feedback loop with AKT/HIF-1α signaling. Am J Cancer Res. 2021;11(1):123–137.33520364
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhang D, Zhang Z, et al. MicroRNA-505, suppressed by oncogenic long non-coding RNA LINC01448, acts as a novel suppressor of glycolysis and tumor progression through inhibiting HK2 expression in pancreatic cancer. Front Cell Dev Biol. 2020;8:625056. doi:10.3389/fcell.2020.62505633520999
   PubMed Web of Science ®Google Scholar
• Liu Y, He D, Xiao M, Zhu Y, Zhou J, Cao K. Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p/HIF-1α negative feedback loop in melanoma. Cell Death Dis. 2021;12(3):245. doi:10.1038/s41419-021-03523-z33664256
   PubMed Web of Science ®Google Scholar
• Pei LJ, Sun PJ, Ma K, Guo YY, Wang LY, Liu FD. LncRNA-SNHG7 interferes with miR-34a to de-sensitize gastric cancer cells to cisplatin. Cancer Biomark. 2020. doi:10.3233/cbm-201621
   Web of Science ®Google Scholar
• Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4566. doi:10.1158/0008-5472.Can-18-396231350295
   PubMed Web of Science ®Google Scholar
• Avagliano A, Fiume G, Pelagalli A, et al. Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front Oncol. 2020;10:722. doi:10.3389/fonc.2020.0072232528879
   PubMed Web of Science ®Google Scholar
• Xu S, Herschman HR. A tumor agnostic therapeutic strategy for hexokinase 1-null/hexokinase 2-positive cancers. Cancer Res. 2019;79(23):5907–5914. doi:10.1158/0008-5472.Can-19-178931434645
   PubMed Web of Science ®Google Scholar
• Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer. 2004;4(11):891–899. doi:10.1038/nrc147815516961
   PubMed Web of Science ®Google Scholar
• Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol. 2014;32:609–634. doi:10.1146/annurev-immunol-032713-12023624655299
   PubMed Web of Science ®Google Scholar
• Lu J, Tan M, Cai Q. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. Cancer Lett. 2015;356(2 Pt A):156–164. doi:10.1016/j.canlet.2014.04.00124732809
   PubMed Web of Science ®Google Scholar
• Wang G, Wang JJ, Yin PH, et al. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy. J Cell Physiol. 2018;234(1):348–368. doi:10.1002/jcp.2691730069931
   PubMed Web of Science ®Google Scholar
• Turpin A, El Amrani M, Bachet JB, Pietrasz D, Schwarz L, Hammel P. Adjuvant pancreatic cancer management: towards new perspectives in 2021. Cancers. 2020;12(12):3866. doi:10.3390/cancers12123866
   PubMed Web of Science ®Google Scholar
• Afonso J, Santos LL, Morais A, Amaro T, Longatto-Filho A, Baltazar F. Metabolic coupling in urothelial bladder cancer compartments and its correlation to tumor aggressiveness. Cell Cycle. 2016;15(3):368–380. doi:10.1080/15384101.2015.112132926636903
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan X, Luo J, Yao H, Si Z, Tong JS. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death Dis. 2020;11(10):902. doi:10.1038/s41419-020-03123-333097691
   PubMed Web of Science ®Google Scholar
• Ng SP, Leong T. Role of radiation therapy in gastric cancer. Ann Surg Oncol. 2021. doi:10.1245/s10434-021-09639-y
   Web of Science ®Google Scholar
• Zhao F, Ming J, Zhou Y, Fan L. Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation. Cancer Chemother Pharmacol. 2016;77(5):963–972. doi:10.1007/s00280-016-3007-927011212
   PubMed Web of Science ®Google Scholar
• Tian RF, Li XF, Xu C, et al. SiRNA targeting PFK1 inhibits proliferation and migration and enhances radiosensitivity by suppressing glycolysis in colorectal cancer. Am J Transl Res. 2020;12(9):4923–4940.33042398
   PubMed Web of Science ®Google Scholar
• Zhao H, Jiang H, Li Z, et al. 2-Methoxyestradiol enhances radiosensitivity in radioresistant melanoma MDA-MB-435R cells by regulating glycolysis via HIF-1α/PDK1 axis. Int J Oncol. 2017;50(5):1531–1540. doi:10.3892/ijo.2017.392428339028
   PubMed Web of Science ®Google Scholar
• Kumari N, Das A, Bhatt AN. Interleukin-6 confers radio-resistance by inducing Akt-mediated glycolysis and reducing mitochondrial damage in cells. J Biochem. 2020;167(3):303–314. doi:10.1093/jb/mvz09131670806
   PubMed Web of Science ®Google Scholar
• Krishna S, Lowery FJ, Copeland AR, et al. Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer. Science. 2020;370(6522):1328–1334. doi:10.1126/science.abb984733303615
   PubMed Web of Science ®Google Scholar
• O’Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019;16(3):151–167. doi:10.1038/s41571-018-0142-830523282
   PubMed Web of Science ®Google Scholar
• Cascone T, McKenzie JA, Mbofung RM, et al. Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy. Cell Metab. 2018;27(5):977–87.e4. doi:10.1016/j.cmet.2018.02.02429628419
   PubMed Web of Science ®Google Scholar
• Rowshanravan B, Halliday N, Sansom DM. CTLA-4: a moving target in immunotherapy. Blood. 2018;131(1):58–67. doi:10.1182/blood-2017-06-74103329118008
   PubMed Web of Science ®Google Scholar
• Chikuma S. CTLA-4, an essential immune-checkpoint for T-cell activation. Curr Top Microbiol Immunol. 2017;410:99–126. doi:10.1007/82_2017_6128900679
   PubMed Web of Science ®Google Scholar
• Zappasodi R, Serganova I, Cohen IJ, et al. CTLA-4 blockade drives loss of T(reg) stability in glycolysis-low tumours. Nature. 2021;591(7851):652–658. doi:10.1038/s41586-021-03326-433588426
   PubMed Web of Science ®Google Scholar
• Pascale RM, Calvisi DF, Simile MM, Feo CF, Feo F. The Warburg effect 97 years after its discovery. Cancers. 2020;12(10):2819. doi:10.3390/cancers12102819
   PubMed Web of Science ®Google Scholar
• Chen LQ, Cheung LS, Feng L, Tanner W, Frommer WB. Transport of sugars. Annu Rev Biochem. 2015;84:865–894. doi:10.1146/annurev-biochem-060614-03390425747398
   PubMed Web of Science ®Google Scholar
• Ancey PB, Contat C, Meylan E. Glucose transporters in cancer - from tumor cells to the tumor microenvironment. FEBS J. 2018;285(16):2926–2943. doi:10.1111/febs.1457729893496
   PubMed Web of Science ®Google Scholar
• Zhou D, Jiang L, Jin L, Yao Y, Wang P, Zhu X. Glucose transporter-1 cooperating with AKT signaling promote gastric cancer progression. Cancer Manag Res. 2020;12:4151–4160. doi:10.2147/cmar.S25159632581586
   PubMed Web of Science ®Google Scholar
• Deng D, Xu C, Sun P, et al. Crystal structure of the human glucose transporter GLUT1. Nature. 2014;510(7503):121–125. doi:10.1038/nature1330624847886
   PubMed Web of Science ®Google Scholar
• Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34(2–3):121–138. doi:10.1016/j.mam.2012.07.00123506862
   PubMed Web of Science ®Google Scholar
• Leto D, Saltiel AR. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat Rev Mol Cell Biol. 2012;13(6):383–396. doi:10.1038/nrm335122617471
   PubMed Web of Science ®Google Scholar
• Tsai TH, Yang CC, Kou TC, et al. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment. J Cell Physiol. 2021;236(6):4669–4680. doi:10.1002/jcp.3018933421130
   PubMed Web of Science ®Google Scholar
• Zambrano A, Molt M, Uribe E, Salas M. Glut 1 in cancer cells and the inhibitory action of resveratrol as a potential therapeutic strategy. Int J Mol Sci. 2019;20(13):3374. doi:10.3390/ijms20133374
   PubMed Web of Science ®Google Scholar
• Mao A, Zhou X, Liu Y, Ding J, Miao A, Pan G. KLF8 is associated with poor prognosis and regulates glycolysis by targeting GLUT4 in gastric cancer. J Cell Mol Med. 2019;23(8):5087–5097. doi:10.1111/jcmm.1437831124603
   PubMed Web of Science ®Google Scholar
• Garrido P, Osorio FG, Morán J, et al. Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells. J Cell Physiol. 2015;230(1):191–198. doi:10.1002/jcp.2469824931902
   PubMed Web of Science ®Google Scholar
• Ellis BC, Graham LD, Molloy PL. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Biochim Biophys Acta. 2014;1843(2):372–386. doi:10.1016/j.bbamcr.2013.10.01624184209
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang X, Wang Z, et al. LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis. Cancer Lett. 2018;434:172–183. doi:10.1016/j.canlet.2018.07.01630026052
   PubMed Web of Science ®Google Scholar
• Chang L, Xu W, Zhang Y, Gong F. Long non-coding RNA-NEF targets glucose transportation to inhibit the proliferation of non-small-cell lung cancer cells. Oncol Lett. 2019;17(3):2795–2801. doi:10.3892/ol.2019.991930854054
   PubMed Web of Science ®Google Scholar
• Shi Z, Guo F, Jia D, et al. Long non-coding RNA mortal obligate RNA transcript suppresses tumor cell proliferation in prostate carcinoma by inhibiting glucose uptake. Oncol Lett. 2019;18(4):3787–3791. doi:10.3892/ol.2019.1071131516590
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/s0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Han TS, Hur K, Cho HS, Ban HS. Epigenetic associations between lncRNA/circRNA and miRNA in hepatocellular carcinoma. Cancers. 2020;12(9):2622. doi:10.3390/cancers12092622
   PubMed Web of Science ®Google Scholar
• Chen XX, Zhang N, Fu XF, Jiang Y, Wang MY. LncRNA DBH-AS1 facilitates the tumorigenesis of melanoma by targeting miR-233-3p via IGF-1R/Akt signaling. Eur Rev Med Pharmacol Sci. 2020;24(14):7698–7708. doi:10.26355/eurrev_202007_2227232744696
   PubMed Web of Science ®Google Scholar
• Zhang C, Liu J, Wu R, et al. Tumor suppressor p53 negatively regulates glycolysis stimulated by hypoxia through its target RRAD. Oncotarget. 2014;5(14):5535–5546. doi:10.18632/oncotarget.213725114038
   PubMedGoogle Scholar
• Zhao Y, Liu Y, Lin L, et al. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1. Mol Cancer. 2018;17(1):69. doi:10.1186/s12943-018-0820-229510730
   PubMed Web of Science ®Google Scholar
• Payen VL, Mina E, Van Hée VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Mol Metab. 2020;33:48–66. doi:10.1016/j.molmet.2019.07.00631395464
   PubMed Web of Science ®Google Scholar
• Logotheti S, Marquardt S, Gupta SK, et al. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during bladder cancer progression as target and co-activator of E2F1. Theranostics. 2020;10(21):9620–9643. doi:10.7150/thno.4417632863950
   PubMed Web of Science ®Google Scholar
• Akram M. Mini-review on glycolysis and cancer. J Cancer Educ. 2013;28(3):454–457. doi:10.1007/s13187-013-0486-923728993
   PubMed Web of Science ®Google Scholar
• Wilson JE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol. 2003;206(Pt 12):2049–2057. doi:10.1242/jeb.0024112756287
   PubMed Web of Science ®Google Scholar
• Al Hasawi N, Alkandari MF, Luqmani YA. Phosphofructokinase: a mediator of glycolytic flux in cancer progression. Crit Rev Oncol Hematol. 2014;92(3):312–321. doi:10.1016/j.critrevonc.2014.05.00724910089
   PubMed Web of Science ®Google Scholar
• Israelsen WJ, Vander Heiden MG. Pyruvate kinase: function, regulation and role in cancer. Semin Cell Dev Biol. 2015;43:43–51. doi:10.1016/j.semcdb.2015.08.00426277545
   PubMed Web of Science ®Google Scholar
• Yin D, Hua L, Wang J, Liu Y, Li X. Long non-coding RNA DUXAP8 facilitates cell viability, migration, and glycolysis in non-small-cell lung cancer via regulating HK2 and LDHA by inhibition of miR-409-3p. Onco Targets Ther. 2020;13:7111–7123. doi:10.2147/ott.S24354232801745
   PubMed Web of Science ®Google Scholar
• Ma Y, Hu M, Zhou L, et al. Long non-coding RNA HOTAIR promotes cancer cell energy metabolism in pancreatic adenocarcinoma by upregulating hexokinase-2. Oncol Lett. 2019;18(3):2212–2219. doi:10.3892/ol.2019.1055131452722
   PubMed Web of Science ®Google Scholar
• Rupaimoole R, Lee J, Haemmerle M, et al. Long noncoding RNA ceruloplasmin promotes cancer growth by altering glycolysis. Cell Rep. 2015;13(11):2395–2402. doi:10.1016/j.celrep.2015.11.04726686630
   PubMed Web of Science ®Google Scholar
• Yang B, Zhang L, Cao Y, et al. Overexpression of lncRNA IGFBP4-1 reprograms energy metabolism to promote lung cancer progression. Mol Cancer. 2017;16(1):154. doi:10.1186/s12943-017-0722-828946875
   PubMed Web of Science ®Google Scholar
• Ule J, Blencowe BJ. Alternative splicing regulatory networks: functions, mechanisms, and evolution. Mol Cell. 2019;76(2):329–345. doi:10.1016/j.molcel.2019.09.01731626751
   PubMed Web of Science ®Google Scholar
• Gu Z, Xia J, Xu H, Frech I, Tricot G, Zhan F. NEK2 promotes aerobic glycolysis in multiple myeloma through regulating splicing of pyruvate kinase. J Hematol Oncol. 2017;10(1):17. doi:10.1186/s13045-017-0392-428086949
   PubMed Web of Science ®Google Scholar
• Lan Z, Yao X, Sun K, Li A, Liu S, Wang X. The interaction between lncRNA SNHG6 and hnRNPA1 contributes to the growth of colorectal cancer by enhancing aerobic glycolysis through the regulation of alternative splicing of PKM. Front Oncol. 2020;10:363. doi:10.3389/fonc.2020.0036332296635
   PubMed Web of Science ®Google Scholar
• Grillone K, Riillo C, Scionti F, et al. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”. J Exp Clin Cancer Res. 2020;39(1):117. doi:10.1186/s13046-020-01622-x32563270
   PubMed Web of Science ®Google Scholar
• Huang JZ, Chen M, Chen D, et al. A peptide encoded by a putative lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell. 2017;68(1):171–84.e6. doi:10.1016/j.molcel.2017.09.01528985503
   PubMed Web of Science ®Google Scholar
• Qian Y, Song W, Wu X, et al. DLX6 antisense RNA 1 modulates glucose metabolism and cell growth in gastric cancer by targeting microRNA-4290. Dig Dis Sci. 2021;66(2):460–473. doi:10.1007/s10620-020-06223-432239379
   PubMed Web of Science ®Google Scholar
• Shen Y, Xu J, Pan X, et al. LncRNA KCNQ1OT1 sponges miR-34c-5p to promote osteosarcoma growth via ALDOA enhanced aerobic glycolysis. Cell Death Dis. 2020;11(4):278. doi:10.1038/s41419-020-2485-132332718
   PubMed Web of Science ®Google Scholar
• Yang W, Zheng Y, Xia Y, et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol. 2012;14(12):1295–1304. doi:10.1038/ncb262923178880
   PubMed Web of Science ®Google Scholar
• Guan YF, Huang QL, Ai YL, et al. Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis. Oncogene. 2020;39(11):2408–2423. doi:10.1038/s41388-020-1158-y31959898
   PubMed Web of Science ®Google Scholar
• Wang C, Li Y, Yan S, et al. Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. Nat Commun. 2020;11(1):3162. doi:10.1038/s41467-020-16966-332572027
   PubMed Web of Science ®Google Scholar
• Xing Z, Zhang Y, Liang K, et al. Expression of long noncoding RNA YIYA promotes glycolysis in breast cancer. Cancer Res. 2018;78(16):4524–4532. doi:10.1158/0008-5472.Can-17-038529967256
   PubMed Web of Science ®Google Scholar
• Shi L, Pan H, Liu Z, Xie J, Han W. Roles of PFKFB3 in cancer. Signal Transduct Target Ther. 2017;2:17044. doi:10.1038/sigtrans.2017.4429263928
   PubMed Web of Science ®Google Scholar
• Bian Z, Zhang J, Li M, et al. LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling. Clin Cancer Res. 2018;24(19):4808–4819. doi:10.1158/1078-0432.Ccr-17-296729914894
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang Y, She X, et al. A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy. J Hematol Oncol. 2018;11(1):77. doi:10.1186/s13045-018-0619-z29866190
   PubMed Web of Science ®Google Scholar
• Zheng F, Chen J, Zhang X, et al. The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis. Nat Commun. 2021;12(1):1341. doi:10.1038/s41467-021-21535-333637716
   PubMed Web of Science ®Google Scholar
• Schito L, Semenza GL. Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer. 2016;2(12):758–770. doi:10.1016/j.trecan.2016.10.01628741521
   PubMed Web of Science ®Google Scholar
• Nagao A, Kobayashi M, Koyasu S, Chow CCT, Harada H. HIF-1-dependent reprogramming of glucose metabolic pathway of cancer cells and its therapeutic significance. Int J Mol Sci. 2019;20(2). doi:10.3390/ijms20020238
   PubMed Web of Science ®Google Scholar
• Yao Z, Zhang Q, Guo F, et al. Long noncoding RNA PCED1B-AS1 promotes the Warburg effect and tumorigenesis by upregulating HIF-1α in glioblastoma. Cell Transplant. 2020;29:963689720906777. doi:10.1177/096368972090677732326742
   PubMed Web of Science ®Google Scholar
• Du Y, Wei N, Ma R, Jiang SH, Song D. Long noncoding RNA MIR210HG promotes the Warburg effect and tumor growth by enhancing HIF-1α translation in triple-negative breast cancer. Front Oncol. 2020;10:580176. doi:10.3389/fonc.2020.58017633392077
   PubMed Web of Science ®Google Scholar
• Strowitzki MJ, Cummins EP, Taylor CT. Protein hydroxylation by hypoxia-inducible factor (HIF) hydroxylases: unique or ubiquitous? Cells. 2019;8(5):384. doi:10.3390/cells8050384
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang H, Mei Y, Wu M. Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. Mol Cell. 2014;53(1):88–100. doi:10.1016/j.molcel.2013.11.00424316222
   PubMed Web of Science ®Google Scholar
• Lin A, Li C, Xing Z, et al. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18(2):213–224. doi:10.1038/ncb329526751287
   PubMed Web of Science ®Google Scholar
• Baluapuri A, Wolf E, Eilers M. Target gene-independent functions of MYC oncoproteins. Nat Rev Mol Cell Biol. 2020;21(5):255–267. doi:10.1038/s41580-020-0215-232071436
   PubMed Web of Science ®Google Scholar
• Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer. Cancer Discov. 2015;5(10):1024–1039. doi:10.1158/2159-8290.Cd-15-050726382145
   PubMed Web of Science ®Google Scholar
• Hung CL, Wang LY, Yu YL, et al. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014;111(52):18697–18702. doi:10.1073/pnas.141566911225512540
   PubMed Web of Science ®Google Scholar
• Tang J, Yan T, Bao Y, et al. LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc. Nat Commun. 2019;10(1):3499. doi:10.1038/s41467-019-11447-831375671
   PubMed Web of Science ®Google Scholar
• Rodic S, Vincent MD. Reactive oxygen species (ROS) are a key determinant of cancer’s metabolic phenotype. Int J Cancer. 2018;142(3):440–448. doi:10.1002/ijc.3106928940517
   PubMed Web of Science ®Google Scholar
• Xiang S, Gu H, Jin L, Thorne RF, Zhang XD, Wu M. LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect. Proc Natl Acad Sci U S A. 2018;115(7):E1465–e74. doi:10.1073/pnas.171125711529378948
   PubMed Web of Science ®Google Scholar
• Pan Y, Mansfield KD, Bertozzi CC, et al. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Mol Cell Biol. 2007;27(3):912–925. doi:10.1128/mcb.01223-0617101781
   PubMed Web of Science ®Google Scholar
• Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74–88. doi:10.1038/s41568-019-0216-731686003
   PubMed Web of Science ®Google Scholar
• Wang B, Shen Y, Zou Y, et al. TOP2A promotes cell migration, invasion and epithelial-mesenchymal transition in cervical cancer via activating the PI3K/AKT signaling. Cancer Manag Res. 2020;12:3807–3814. doi:10.2147/cmar.S24057732547216
   PubMed Web of Science ®Google Scholar
• Menon S, Dibble CC, Talbott G, et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell. 2014;156(4):771–785. doi:10.1016/j.cell.2013.11.04924529379
   PubMed Web of Science ®Google Scholar
• Parsons R. Discovery of the PTEN tumor suppressor and its connection to the PI3K and AKT oncogenes. Cold Spring Harb Perspect Med. 2020;10(8):a036129. doi:10.1101/cshperspect.a03612931932465
   PubMed Web of Science ®Google Scholar
• Li W, Huang K, Wen F, et al. LINC00184 silencing inhibits glycolysis and restores mitochondrial oxidative phosphorylation in esophageal cancer through demethylation of PTEN. EBioMedicine. 2019;44:298–310. doi:10.1016/j.ebiom.2019.05.05531201145
   PubMed Web of Science ®Google Scholar
• Zou ZW, Ma C, Medoro L, et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget. 2016;7(38):61741–61754. doi:10.18632/oncotarget.1143727557514
   PubMedGoogle Scholar
• Li Z, Li X, Wu S, Xue M, Chen W. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway. Cancer Sci. 2014;105(8):951–955. doi:10.1111/cas.1246124890811
   PubMed Web of Science ®Google Scholar
• Zheng YL, Li L, Jia YX, et al. LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt/mTOR signaling pathway. Theranostics. 2019;9(3):796–810. doi:10.7150/thno.2899230809309
   PubMed Web of Science ®Google Scholar
• Shaw LM. The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer. Cell Cycle. 2011;10(11):1750–1756. doi:10.4161/cc.10.11.1582421597332
   PubMed Web of Science ®Google Scholar
• Cheng Z, Luo C, Guo Z. LncRNA-XIST/microRNA-126 sponge mediates cell proliferation and glucose metabolism through the IRS1/PI3K/Akt pathway in glioma. J Cell Biochem. 2020;121(3):2170–2183. doi:10.1002/jcb.2944031680298
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006;7(2):85–96. doi:10.1038/nrm183716493415
   PubMed Web of Science ®Google Scholar
• Faubert B, Boily G, Izreig S, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013;17(1):113–124. doi:10.1016/j.cmet.2012.12.00123274086
   PubMed Web of Science ®Google Scholar
• Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19(2):121–135. doi:10.1038/nrm.2017.9528974774
   PubMed Web of Science ®Google Scholar
• Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 2003;115(5):577–590. doi:10.1016/s0092-8674(03)00929-214651849
   PubMed Web of Science ®Google Scholar
• Nguyen HB, Babcock JT, Wells CD, Quilliam LA. LKB1 tumor suppressor regulates AMP kinase/mTOR-independent cell growth and proliferation via the phosphorylation of Yap. Oncogene. 2013;32(35):4100–4109. doi:10.1038/onc.2012.43123027127
   PubMed Web of Science ®Google Scholar
• Hezel AF, Bardeesy N. LKB1; linking cell structure and tumor suppression. Oncogene. 2008;27(55):6908–6919. doi:10.1038/onc.2008.34219029933
   PubMed Web of Science ®Google Scholar
• Shackelford DB, Vasquez DS, Corbeil J, et al. mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome. Proc Natl Acad Sci U S A. 2009;106(27):11137–11142. doi:10.1073/pnas.090046510619541609
   PubMed Web of Science ®Google Scholar
• Zeng Q, Chen J, Li Y, et al. LKB1 inhibits HPV-associated cancer progression by targeting cellular metabolism. Oncogene. 2017;36(9):1245–1255. doi:10.1038/onc.2016.29027546620
   PubMed Web of Science ®Google Scholar
• Chen Z, Li JL, Lin S, et al. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. J Clin Invest. 2016;126(6):2267–2279. doi:10.1172/jci8525027140397
   PubMed Web of Science ®Google Scholar
• Kim SJ, Ju JS, Park SS, et al. An RNA-binding-protein, NONO governs energy metabolism by regulating NAMPT in lung cancer. Biochem Biophys Res Commun. 2020;528(2):376–382. doi:10.1016/j.bbrc.2020.01.01132087970
   PubMed Web of Science ®Google Scholar
• Liu X, Xiao ZD, Han L, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress. Nat Cell Biol. 2016;18(4):431–442. doi:10.1038/ncb332826999735
   PubMed Web of Science ®Google Scholar
• Yang W, Zheng Z, Yi P, et al. LncRNA NBR2 inhibits the malignancy of thyroid cancer, associated with enhancing the AMPK signaling. Front Oncol. 2020;10:956. doi:10.3389/fonc.2020.0095632596161
   PubMed Web of Science ®Google Scholar
• Bensaad K, Vousden KH. p53: new roles in metabolism. Trends Cell Biol. 2007;17(6):286–291. doi:10.1016/j.tcb.2007.04.00417481900
   PubMed Web of Science ®Google Scholar
• Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004;64(7):2627–2633. doi:10.1158/0008-5472.can-03-084615059920
   PubMed Web of Science ®Google Scholar
• Kondoh H, Lleonart ME, Gil J, et al. Glycolytic enzymes can modulate cellular life span. Cancer Res. 2005;65(1):177–185.15665293
   PubMed Web of Science ®Google Scholar
• Zhou Y, Niu W, Luo Y, et al. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53. Cancer Sci. 2019;110(3):939–949. doi:10.1111/cas.1392830618169
   PubMed Web of Science ®Google Scholar
• Chen R, Liu Y, Zhuang H, et al. Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation. Nucleic Acids Res. 2017;45(17):9947–9959. doi:10.1093/nar/gkx60028973437
   PubMed Web of Science ®Google Scholar
• Uroda T, Anastasakou E, Rossi A, et al. Conserved pseudoknots in lncRNA MEG3 are essential for stimulation of the p53 pathway. Mol Cell. 2019;75(5):982–95.e9. doi:10.1016/j.molcel.2019.07.02531444106
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu J, Jing H, Huang G, Sun Z, Xu S. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53. J Cell Biochem. 2019;120(4):6789–6797. doi:10.1002/jcb.2798230556250
   PubMed Web of Science ®Google Scholar
• Lee SY, Jeon HM, Ju MK, et al. Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism. Cancer Res. 2012;72(14):3607–3617. doi:10.1158/0008-5472.Can-12-000622637725
   PubMed Web of Science ®Google Scholar
• Pate KT, Stringari C, Sprowl-Tanio S, et al. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J. 2014;33(13):1454–1473. doi:10.15252/embj.20148859824825347
   PubMed Web of Science ®Google Scholar
• Zhang H, Qin D, Jiang Z, Zhang J. SNHG9/miR-199a-5p/Wnt2 axis regulates cell growth and aerobic glycolysis in glioblastoma. J Neuropathol Exp Neurol. 2019;78(10):939–948. doi:10.1093/jnen/nlz07831504670
   PubMed Web of Science ®Google Scholar
• Kang R, Yao DF, Xu GZ, Zhou YH. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway. Neoplasma. 2020;67(5):1094–1105. doi:10.4149/neo_2020_191022N107332538668
   PubMed Web of Science ®Google Scholar
• Harvey KF, Zhang X, Thomas DM. The Hippo pathway and human cancer. Nat Rev Cancer. 2013;13(4):246–257. doi:10.1038/nrc345823467301
   PubMed Web of Science ®Google Scholar
• Lin X, Feng D, Li P, Lv Y. LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway. Cancer Med. 2020;9(21):8122–8132. doi:10.1002/cam4.332232918541
   PubMed Web of Science ®Google Scholar
• Zheng X, Han H, Liu GP, et al. LncRNA wires up Hippo and Hedgehog signaling to reprogramme glucose metabolism. EMBO J. 2017;36(22):3325–3335. doi:10.15252/embj.20179760928963395
   PubMed Web of Science ®Google Scholar
• Hao Y, Baker D, Ten Dijke P. TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767. doi:10.3390/ijms20112767
   PubMed Web of Science ®Google Scholar
• Mota MSV, Jackson WP, Bailey SK, et al. Deficiency of tumor suppressor Merlin facilitates metabolic adaptation by co-operative engagement of SMAD-Hippo signaling in breast cancer. Carcinogenesis. 2018;39(9):1165–1175. doi:10.1093/carcin/bgy07829893810
   PubMed Web of Science ®Google Scholar
• Wu HZ, Xiao JQ, Xiao SS, Cheng Y. KRAS: a promising therapeutic target for cancer treatment. Curr Top Med Chem. 2019;19(23):2081–2097. doi:10.2174/156802661966619090516414431486755
   PubMed Web of Science ®Google Scholar
• Pupo E, Avanzato D, Middonti E, Bussolino F, Lanzetti L. KRAS-driven metabolic rewiring reveals novel actionable targets in cancer. Front Oncol. 2019;9:848. doi:10.3389/fonc.2019.0084831544066
   PubMed Web of Science ®Google Scholar
• Zhai H, Zhang X, Sun X, Zhang D, Ma S. Long non-coding RNA LINC01420 contributes to pancreatic cancer progression through targeting KRAS proto-oncogene. Dig Dis Sci. 2020;65(4):1042–1052. doi:10.1007/s10620-019-05829-731562613
   PubMed Web of Science ®Google Scholar
• Zhai X, Xu W. Long noncoding RNA ATB promotes proliferation, migration, and invasion in bladder cancer by suppressing microRNA-126. Oncol Res. 2018;26(7):1063–1072. doi:10.3727/096504018x1515207209847629321082
   PubMed Web of Science ®Google Scholar
• Yang W, Redpath RE, Zhang C, Ning N. Long non-coding RNA H19 promotes the migration and invasion of colon cancer cells via MAPK signaling pathway. Oncol Lett. 2018;16(3):3365–3372. doi:10.3892/ol.2018.905230127936
   PubMed Web of Science ®Google Scholar
• Zhai S, Xu Z, Xie J, et al. Epigenetic silencing of LncRNA LINC00261 promotes c-myc-mediated aerobic glycolysis by regulating miR-222-3p/HIPK2/ERK axis and sequestering IGF2BP1. Oncogene. 2021;40(2):277–291. doi:10.1038/s41388-020-01525-3
   Google Scholar
• Schulte JH, Kirfel J, Lim S, et al. Transcription factor AP2alpha (TFAP2a) regulates differentiation and proliferation of neuroblastoma cells. Cancer Lett. 2008;271(1):56–63. doi:10.1016/j.canlet.2008.05.03918620802
   PubMed Web of Science ®Google Scholar
• Zhang G, Ma A, Jin Y, Pan G, Wang C. LncRNA SNHG16 induced by TFAP2A modulates glycolysis and proliferation of endometrial carcinoma through miR-490-3p/HK2 axis. Am J Transl Res. 2019;11(11):7137–7145.31814916
   PubMed Web of Science ®Google Scholar
• Hua Q, Jin M, Mi B, et al. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol. 2019;12(1):91. doi:10.1186/s13045-019-0773-y31488218
   PubMed Web of Science ®Google Scholar
• Liu J, Liu ZX, Wu QN, et al. Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming. Nat Commun. 2020;11(1):1507. doi:10.1038/s41467-020-15112-332198345
   PubMed Web of Science ®Google Scholar
• Liao M, Liao W, Xu N, et al. LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2. EBioMedicine. 2019;41:200–213. doi:10.1016/j.ebiom.2019.01.03530796006
   PubMed Web of Science ®Google Scholar
• Yu T, Guo F, Yu Y, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy. Cell. 2017;170(3):548–63.e16. doi:10.1016/j.cell.2017.07.00828753429
   PubMed Web of Science ®Google Scholar
• Hong J, Guo F, Lu SY, et al. F. nucleatum targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer. Gut. 2020. doi:10.1136/gutjnl-2020-322780
   Web of Science ®Google Scholar
• Hua Q, Mi B, Xu F, et al. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis. Theranostics. 2020;10(11):4762–4778. doi:10.7150/thno.4383932308748
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Hamblin MR. Regulation of glycolysis by non-coding RNAs in cancer: switching on the Warburg effect. Mol Ther Oncolytics. 2020;19:218–239. doi:10.1016/j.omto.2020.10.00333251334
   PubMed Web of Science ®Google Scholar
• Ding X, Liu J, Liu T, Ma Z, Wen D, Zhu J. miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. Cancer Med. 2017;6(6):1301–1310. doi:10.1002/cam4.100828440026
   PubMed Web of Science ®Google Scholar
• Chen YH, Song Y, Yu YL, Cheng W, Tong X. miRNA-10a promotes cancer cell proliferation in oral squamous cell carcinoma by upregulating GLUT1 and promoting glucose metabolism. Oncol Lett. 2019;17(6):5441–5446. doi:10.3892/ol.2019.1025731186763
   PubMed Web of Science ®Google Scholar
• Fei X, Qi M, Wu B, Song Y, Wang Y, Li T. MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression. FEBS Lett. 2012;586(4):392–397. doi:10.1016/j.febslet.2012.01.00622265971
   PubMed Web of Science ®Google Scholar
• Zhang K, Zhang M, Jiang H, Liu F, Liu H, Li Y. Down-regulation of miR-214 inhibits proliferation and glycolysis in non-small-cell lung cancer cells via down-regulating the expression of hexokinase 2 and pyruvate kinase isozyme M2. Biomed Pharmacother. 2018;105:545–552. doi:10.1016/j.biopha.2018.06.00929886375
   PubMed Web of Science ®Google Scholar
• Wang J, Wang H, Liu A, Fang C, Hao J, Wang Z. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget. 2015;6(23):19456–19468. doi:10.18632/oncotarget.331826062441
   PubMedGoogle Scholar
• Li Q, Pan X, Zhu D, Deng Z, Jiang R, Wang X. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019;70(4):1298–1316. doi:10.1002/hep.3067131004447
   PubMed Web of Science ®Google Scholar
• Zheng Z, Ma X, Li H. Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2. J Cell Mol Med. 2020;24(13):7531–7537. doi:10.1111/jcmm.1538032410389
   PubMed Web of Science ®Google Scholar
• Pan Z, Cai J, Lin J, et al. A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer. Mol Cancer. 2020;19(1):71. doi:10.1186/s12943-020-01179-532241279
   PubMed Web of Science ®Google Scholar
• Fan L, Huang C, Li J, Gao T, Lin Z, Yao T. Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer. Int J Mol Med. 2018;42(4):2247–2259. doi:10.3892/ijmm.2018.377830015920
   PubMed Web of Science ®Google Scholar
• Sakai T, Matsuo Y, Okuda K, et al. Development of antitumor biguanides targeting energy metabolism and stress responses in the tumor microenvironment. Sci Rep. 2021;11(1):4852. doi:10.1038/s41598-021-83708-w33649449
   PubMed Web of Science ®Google Scholar
• García Rubiño ME, Carrillo E, Ruiz Alcalá G, et al. Phenformin as an anticancer agent: challenges and prospects. Int J Mol Sci. 2019;20(13):3316. doi:10.3390/ijms2013
   PubMed Web of Science ®Google Scholar
• Liu X, Gan B. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1. Cell Cycle. 2016;15(24):3471–3481. doi:10.1080/15384101.2016.124954527792451
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen G, Gao Y, Liang H. HOTAIR/miR-125 axis-mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma. J Cell Mol Med. 2020;24(10):5707–5717. doi:10.1111/jcmm.1523332279420
   PubMed Web of Science ®Google Scholar
• Zheng H, Zhang M, Ke X, et al. LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1. Cancer Biomark. 2020. doi:10.3233/cbm-201740
   Web of Science ®Google Scholar
• Fu J, Shi H, Wang B, et al. LncRNA PVT1 links Myc to glycolytic metabolism upon CD4(+) T cell activation and Sjögren’s syndrome-like autoimmune response. J Autoimmun. 2020;107:102358. doi:10.1016/j.jaut.2019.10235831757716
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Z, Chen X, Zhang S. Long non-coding RNAs: from disease code to drug role. Acta Pharm Sin B. 2021;11(2):340–354. doi:10.1016/j.apsb.2020.10.00133643816
   PubMed Web of Science ®Google Scholar
• Xu S, Jia G, Zhang H, et al. LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis. Life Sci. 2021;264:118636. doi:10.1016/j.lfs.2020.11863633148416
   PubMed Web of Science ®Google Scholar
• Jiang W, Kai J, Li D, Wei Z, Wang Y, Wang W. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway. J Cell Physiol. 2020;235(10):7194–7203. doi:10.1002/jcp.2961832039488
   PubMed Web of Science ®Google Scholar
• Papaioannou D, Petri A, Dovey OM, et al. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nat Commun. 2019;10(1):5351. doi:10.1038/s41467-019-13259-231767858
   PubMed Web of Science ®Google Scholar
• Zhang XM, Chen H, Zhou B, et al. lncRNA HOXB-AS3 promotes hepatoma by inhibiting p53 expression. Eur Rev Med Pharmacol Sci. 2018;22(20):6784–6792. doi:10.26355/eurrev_201810_1614530402841
   PubMed Web of Science ®Google Scholar
• Tian S, Yu Y, Huang H, Xu A, Xu H, Zhou Y. Expression level and clinical significance of NKILA in human cancers: a systematic review and meta-analysis. Biomed Res Int. 2020;2020:4540312. doi:10.1155/2020/454031232851072
   PubMed Web of Science ®Google Scholar
• Chen Z, Li S, Shen L, et al. NF-kappa B interacting long noncoding RNA enhances the Warburg effect and angiogenesis and is associated with decreased survival of patients with gliomas. Cell Death Dis. 2020;11(5):323. doi:10.1038/s41419-020-2520-232382013
   PubMed Web of Science ®Google Scholar
• Crooke ST. Molecular mechanisms of antisense oligonucleotides. Nucleic Acid Ther. 2017;27(2):70–77. doi:10.1089/nat.2016.065628080221
   PubMed Web of Science ®Google Scholar
• Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F. Rationally engineered Cas9 nucleases with improved specificity. Science. 2016;351(6268):84–88. doi:10.1126/science.aad522726628643
   PubMed Web of Science ®Google Scholar
• Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA. Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Nat Biotechnol. 2019;37(6):657–666. doi:10.1038/s41587-019-0095-130988504
   PubMed Web of Science ®Google Scholar
• Lee JK, Jeong E, Lee J, et al. Directed evolution of CRISPR-Cas9 to increase its specificity. Nat Commun. 2018;9(1):3048. doi:10.1038/s41467-018-05477-x30082838
   PubMed Web of Science ®Google Scholar